Creating an open research environment
World‑leading academic research invariably requires commercial partners to develop each generation of life science discoveries into new treatments.
The research building is therefore designed to attract private‑sector pharmaceutical, biotech and start‑up companies to work alongside, and in close collaboration with, leading clinicians and successful academic teams.
The aim is to create a powerful “open research” environment that accelerates the transition of fundamental academic discoveries through clinical trials into widely available new treatments.
Co‑location at scale in Headington
This development cycle is a well‑documented route for successfully delivering the benefits of innovation.
The Warneford site offers the last opportunity for private‑sector companies to co‑locate at scale with clinicians and academic researchers on the Headington NHS estate.
The building’s dynamic, curved design will mark its prominent position at the gateway to the adjoining Old Road Campus, which lies at the heart of the UK’s largest and top‑ranked University Medical Sciences Division.
Accelerating translation for public benefit
The intention of the Radcliffe Research Building is to integrate research and development value systems and to harness their combined resources as closely and symbiotically as possible, for mutual and national benefit.
Proximity to the hospital will ensure discoveries can be translated efficiently into treatments, speeding up clinical trial times and improving patient outcomes.